TREMFYA One-Press Patient Controlled Injector Approved for Plaque Psoriasis

TREMFYA One-Press Patient Controlled Injector Approved for Plaque Psoriasis

February 27th, 2019 Editors Dermatology, Medicine

The Janssen Pharma, a part of Johnson & Johnson, won FDA approval for its TREMFYA One-Press single-dose injector. The device is used to deliver TREMFYA (guselkumab) as a treatment for moderate to severe plaque…

TREMFYA One-Press Patient Controlled Injector Approved for Plaque Psoriasis

TREMFYA One-Press Patient Controlled Injector Approved for Plaque Psoriasis

February 27th, 2019 Editors Dermatology, Medicine

The Janssen Pharma, a part of Johnson & Johnson, won FDA approval for its TREMFYA One-Press single-dose injector. The device is used to deliver TREMFYA (guselkumab) as a treatment for moderate to severe plaque…

TREMFYA One-Press Patient Controlled Injector Approved for Plaque Psoriasis

TREMFYA One-Press Patient Controlled Injector Approved for Plaque Psoriasis

February 27th, 2019 Editors Dermatology, Medicine

The Janssen Pharma, a part of Johnson & Johnson, won FDA approval for its TREMFYA One-Press single-dose injector. The device is used to deliver TREMFYA (guselkumab) as a treatment for moderate to severe plaque…